• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Apotea

76.70 SEK

+1.46 %

Less than 1K followers

APOTEA

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.46 %
-4.24 %
+33.30 %
-16.83 %
-11.97 %
-20.25 %
-
-
-8.69 %

Apotea is active in the e-commerce sector. The company operates as an online pharmacy. The company sells and supplies a wide range of prescription and over-the-counter medicines, skin and hair care products as well as make-up and various beauty-related products. The company operates in the Swedish domestic market, where the customer base mainly consists of private individuals. Apotea was founded in 2003 and has its headquarters in Stockholm.

Read more
Market cap
8.1B SEK
Turnover
20.04M SEK
Revenue
7.2B
EBIT %
4.14 %
P/E
34.86
Dividend yield-%
0.78 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
17/7
2026

Interim report Q2'26

5/11
2026

Interim report Q3'26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press releaseyesterday

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea
Regulatory press release5/29/2026, 5:30 AM

Antal aktier och röster i Apotea

Apotea
Regulatory press release5/29/2026, 5:30 AM

Number of shares and votes in Apotea

Apotea

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/26/2026, 2:30 PM

Kommuniké från årsstämma den 26 maj 2026 i Apotea AB (publ)

Apotea
Regulatory press release5/26/2026, 2:30 PM

Bulletin from Apotea AB’s (publ) Annual General Meeting on May 26, 2026

Apotea
Apotea, Webcast, Q1'26
Webcast4/29/2026, 7:30 AM

Apotea, Webcast, Q1'26

Apotea
Regulatory press release4/29/2026, 5:30 AM

Apotea AB (publ) delårsrapport Q1 2026: Starkt rörelseresultat och stabil tillväxt

Apotea
Regulatory press release4/29/2026, 5:30 AM

Apotea AB (publ) interim report Q1 2026: Strong operating profit and stable growth

Apotea
Regulatory press release4/17/2026, 9:05 AM

Kallelse till årsstämma i Apotea AB (publ)

Apotea
Regulatory press release4/17/2026, 9:05 AM

Notice to annual general meeting in Apotea AB (publ)

Apotea
Regulatory press release4/17/2026, 5:30 AM

Apotea publicerar årsredovisning och hållbarhetsrapport för räkenskapsåret 2025

Apotea
Regulatory press release4/17/2026, 5:30 AM

Apotea publishes annual and sustainability report for the financial year 2025

Apotea
Press release4/7/2026, 7:00 AM

Inbjudan till Apoteas webcast för det första kvartalet 2026

Apotea
Press release4/7/2026, 7:00 AM

Invitation to Apotea’s Q1 2026 webcast

Apotea
Regulatory press release3/31/2026, 1:00 PM

Valberedningens förslag till styrelse i Apotea AB (publ)

Apotea
Regulatory press release3/31/2026, 1:00 PM

The Nomination Committee's proposal for the Board of Directors of Apotea AB (publ)

Apotea
Apotea, Webcast, Q4'25
Webcast2/4/2026, 8:30 AM

Apotea, Webcast, Q4'25

Apotea
Regulatory press release2/4/2026, 6:30 AM

Apotea AB (publ) bokslutskommuniké 2025: Svag lönsamhet i det fjärde kvartalet

Apotea
Regulatory press release2/4/2026, 6:30 AM

Apotea AB (publ) Year-end report 2025: Weak profitability in the fourth quarter

Apotea
Regulatory press release2/3/2026, 9:55 AM

Finansinspektionen: Flaggningsmeddelande i Apotea AB (publ)

Apotea